Gattefosse : Labrasol® http://www.gattefosse.com/products-kwx/-labrasol®-.html?administr...

This page comme from the website Gattefosse. It was printed the le 2011-03-24 : 17:08. The original page is available at this
address : .

PHARMACEUTICALS

Labrasol®
Caprylocaproyl macrogol-8 glycerides EP
Caprylocaproyl polyoxyl-8 glycerides NF

Key Features
Oral
•A non-ionic water dispersible surfactant composed of well-characterised polyethylene glycol (PEG) esters,
a small glyceride fraction and free PEG.

•Able to self-emulsify on contact with aqueous media forming a fine dispersion ie. microemulsion
(SMEDDS).

•Solubilizer and wetting agent: Surfactive power improves the solubility and wettability of active
pharmaceutical ingredients in vitro and in vivo.

•Bioavailability enhancer: Increased bioavailability is reported to be associated with strong inhibition of the
enterocytic efflux transporter (known as P-gP inhibition).

Topical
•An oil-in-water surfactant used to solubilize active pharmaceutical ingredients and promote drug
penetration and permeation.

Safety of use is supported by extensive toxicological evaluations and precedence of use in approved
pharmaceutical products.

1 of 2 3/24/2011 7:09 PM
Gattefosse : Labrasol® http://www.gattefosse.com/products-kwx/-labrasol®-.html?administr...

Physical Form

liquid

Hydrophilic-lipophilic Balance

14

Field of use

•Human pharmaceutical products, veterinary products excluding food producing animals

Administration Route

Oral

Formulation techniques and dosage forms

•Suitable for hard gelatin and soft gelatin capsules.

•Suitable for adsorption onto neutral carrier powders for use in tablets, capsule filling and sachets.
•Use in topical ointments, microemulsions, emulsions and gels.
•Use in transdermal patches.

2 of 2 3/24/2011 7:09 PM